Distributor Appointed in South Korea

 
TIDMRGT 
 
ReGen Signs Agreement for the Distribution of its Nutraceutical ColostrininTM in 
South Korea with LG Life Sciences 
 
01/12/2010 
 
ReGen Therapeutics Plc ('ReGen') is pleased to announce that it has today signed 
an agreement with LG Life Sciences, Ltd ('LGLS'), appointing them as the 
exclusive distributor of its nutritional supplement Colostrinin(TM) in South 
Korea. 
 
LGLS is the leading pharmaceutical company based in Seoul, Korea, committed to 
promoting health and well being of patients and customers. Its key therapeutic 
areas include metabolic and cardiovascular diseases as well as well-being. In 
parallel LGLS has a unique capability to develop and market nutraceutical 
products and has a plan to distribute Colostrinin(TM) through various shopping 
channels. Additional information is available on its corporate website, 
www.lgls.co.kr. 
 
This appointment is conditional upon LGLS securing import and regulatory 
approval for the product. An application to gain approval should be submitted 
before the end of the first quarter of 2011 but approval may take some 
considerable time to achieve. LGLS will also be developing their own formulation 
of Colostrinin(TM) specifically tailored to the retail market in South Korea. No 
further details of the agreement will be disclosed at this time. 
 
To date Colostrinin(TM) is marketed as a nutritional supplement to 'support 
healthy brain aging and cognition in humans' in the US, Canada, Australia and 
Poland under the brand name CogniSure(TM) *, in Cyprus under the brand name 
Cognase(TM) **, in the UK under the brand name MemoryAid (TM) ***, in Turkey 
under the brand name Dyna(TM)  **** and in India under the brand name Cognate 
(TM)  ***** 
 
The ReGen Board regards this is a significant step for ReGen as it provides 
entry into the major growth area of the world economy.  It is very important in 
the context of the accelerated roll out programme for Colostrinin(TM). 
 
 
 
*         Colostrinin(TM) for use as a human nutraceutical is licensed in North 
America and Australasia to Metagenics Inc. of San Clemente, California 
(www.metagenics.com). 
 
            Colostrinin(TM)  is distributed in Poland by Tagerr Polska,  an 
affliate of Tagerr a professional services and trading company  established in 
Köln, Germany. (www.cognisure.eu) 
 
**        Colostrinin(TM) is distributed in the Republic of Cyprus by Golgi 
Pharmaceuticals Ltd (www.healthybrainaging.com). 
 
***      Colostrinin(TM) is distributed in the UK by PRG Nutraceuticals Ltd 
(www.memoryaid.com) 
 
****    Colostrinin(TM) is distributed in Turkey by Eczacibasi Ilac Pazarlama 
A.S (www.eczacibasi.com) 
 
*****   Colostrinin(TM) is distributed in India by USV Ltd (www.usvindia.com ) 
 
 
 
For further information: 
 
Percy Lomax 
ReGen Therapeutics Plc 
Tel No 020 7153 4920 
 
Roland Cornish/Felicity Geidt 
Beaumont Cornish Limited 
Tel No 020 7628 3396 
 
Nick Bealer/David Scott 
Alexander David 
Tel No 020 7448 9820 
 
 
 
 
 
 
[HUG#1467514] 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE